Measurement of CA15-3 level among women attending the surgery department at Brack General Hospital – South of Libya

Authors

  • Ebraheem A. Eshnaf
  • Maryam M. Bisher
  • Sara Mousa
  • Amna Ezzat
  • Naiima Massoud

DOI:

https://doi.org/10.51984/joms.v17i2.2287

Keywords:

Breast cancer, CA15-3, Tumor marker, Diagnosis

Abstract

CA15-3 is one of the most widely used tumor markers for diagnosing and monitoring therapy of breast cancer. However, scientific studies have differed significantly in the importance of measuring this antigen for early diagnosis of breast cancer.The study was conducted on 72 women who visited the surgery department of the Brack general hospital, The concentration of CA15-3 was measured using enzyme-linked immunosorbent assay (ELISA).The results showed that the level of CA15-3 was elevated in 2 samples (2.77%) with  a mean level of 38.5 ± 1.7 U/ mL, and 70 samples (97.23%) was were normal with  a mean level of 13.77 ± 6.17 U/ml. The statistical analysis showed significant differences between the concentrations in the high and normal samples (P = 0.00). We conclude that CA15-3 is not a reliable test to confirm breast cancer.

Downloads

Download data is not yet available.

Downloads

Published

2022-10-03

How to Cite

Measurement of CA15-3 level among women attending the surgery department at Brack General Hospital – South of Libya. (2022). Journal of Medical Sciences, 17(2), 37-39. https://doi.org/10.51984/joms.v17i2.2287

Similar Articles

1-10 of 24

You may also start an advanced similarity search for this article.